I have an interest in the impact of modifiable lifestyle factors on cancer etiology and survival and I am committed to applying the knowledge gained from my research to the development and testing of novel cancer screening, prevention, and interception strategies. Much of my current work focuses on the prevention and control of multiple myeloma, which is an understudied and incurable plasma cell malignancy. I am particularly interested in identifying novel prevention strategies for individuals diagnosed with monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, which are premalignant blood conditions that progress to overt multiple myeloma in a subset of patients for reasons that are poorly understood.